Want to see BLSM full AI Analyst Report?
BlossomHill Therapeutics, Inc. (BLSM) Ownership - Who Owns BlossomHill Therapeutics, Inc.?
BlossomHill Therapeutics, Inc. (BLSM) Ownership Overview
- 55.71% Insiders
- 1.42% Mutual Funds
- 1.37% ETFs
- 41.50% Public Companies and Individual Investors
The ownership structure of BlossomHill Therapeutics, Inc. (BLSM) stock is a mix of institutional, retail, and individual investors. Approximately 2.79% of the company’s stock is owned by Institutional Investors, 55.71% is owned by Insiders, and 41.50% is owned by Public Companies and Individual Investors.
The ownership structure of BlossomHill Therapeutics, Inc. (BLSM) stock is a mix of institutional, retail, and individual investors. Approximately 2.79% of the company’s stock is owned by Institutional Investors, 55.71% is owned by Insiders, and 41.50% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 11, 2026 | Orbimed Advisors Llc | $10,000,000 | |
| Aug 11, 2026 | Carl Gordon | $10,000,000 | |
| Aug 09, 2026 | Bihua Chen | $5,000,000 | |
| Aug 09, 2026 | John Schmid | $96,000 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Yishan Li | 3,973,138 | Insider | 12.50% | 54,630,648 |
| Jean Cui Jingrong | 3,973,138 | Insider | 12.50% | 54,630,648 |
| Bihua Chen | 3,614,034 | Insider | 11.37% | 49,692,968 |
| Orbimed Advisors Llc | 2,714,279 | Insider | 8.54% | 37,321,336 |
| Carl Gordon | 2,714,279 | Insider | 8.54% | 37,321,336 |
| Sundeep Agrawal | 578,524 | Insider | 1.82% | 7,954,705 |
| Vanguard | 435,554 | Institution | 1.37% | 5,988,868 |
| Fidelity Select Portfolios | 347,400 | Institution | 1.09% | 4,776,750 |
| Vincent Paul Liptak | 134,099 | Insider | 0.42% | 1,843,861 |
| Columbia Funds Series Trust I | 73,691 | Institution | 0.23% | 1,013,251 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Select Portfolios | 347,400 | Institution | 1.09% | 4,776,750 |
| Columbia Funds Series Trust I | 73,691 | Institution | 0.23% | 1,013,251 |
| Valic Co I | 19,632 | Institution | 0.06% | 269,940 |
| Vanguard Scottsdale Funds | 10,932 | Institution | 0.03% | 150,315 |
Top ETF Holders
FAQ
What percentage of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors?
According to the latest TipRanks data, approximately 41.50% of BlossomHill Therapeutics, Inc. (BLSM) stock is held by retail investors.
Who owns the most shares of BlossomHill Therapeutics, Inc. (BLSM)?
Yishan Li owns the most shares of BlossomHill Therapeutics, Inc. (BLSM).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.